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Abstract: The aim of this study was to assess the antioxidant, photoprotective, and antiaging e↵ects of
Greek propolis. Propolis was subjected to n-heptane or methanol extraction. Total phenolic/flavonoid
content and antioxidant potential were determined in the extracts. Promising extracts were evaluated
for their cytoprotective properties using human immortalized keratinocyte (HaCaT) or reconstituted
human skin tissue following exposure to UVB. Assessment of cytotoxicity, DNA damage, oxidative
status, and gene/protein expression levels of various matrix metalloproteinases (MMPs) were
performed. The propolis methanolic fractions exhibited higher total phenolic and flavonoid contents
and significant in vitro antioxidant activity. Incubation of HaCaT cells with certain methanolic
extracts significantly decreased the formation of DNA strand breaks following exposure to UVB
and attenuated UVB-induced decrease in cell viability. The extracts had no remarkable e↵ect on the
total antioxidant status, but significantly lowered total protein carbonyl content used as a marker
for protein oxidation in HaCaT cells. MMP-1, -3, -7, and -9, monitored as endpoints of antiaging
e cacy, were significantly reduced by propolis following UVB exposure in a model of reconstituted
skin tissue. In conclusion, propolis protects against the oxidative and photodamaging e↵ects of UVB
and could be further explored as a promising agent for developing natural antiaging strategies.
Keywords: propolis; antioxidant; antiaging; photoprotective; DNA damage; matrix metalloproteinases;
HaCaT; reconstituted skin
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1. Introduction
Skin comprises the largest organ of the human body and the main barrier protecting the organism
from various pathogens and environmental stressors, including ultraviolet radiation (UVR) [1]. UVR is
distinguished into UVC (200–280nm), UVB (280–315nm), and UVA (315–400nm) [2]; UVC is absorbed
by the stratosphere, while UVA and UVB are able to penetrate various layers of the skin [3]. UVB
radiation causes a spectrum of DNA modifications, with the most prominent being the formation of
cyclobutane-pyrimidine dimers (CPD) and 8-hydroxy-20-deoxyguanosine adducts [4], which have
been implicated in photo-induced carcinogenesis [5]. UVB radiation can also cause accumulation of
reactive oxygen species (ROS) leading to generation of oxidative stress. To this end, ROS can react
with a variety of biological macromolecules like proteins, DNA, and lipids, causing their oxidation [6].
Noteworthy, through ROS formation, UVB induces activator protein-1 (AP-1) overexpression along
with the upregulation of collagen-degrading enzymes like matrix metalloproteinases (MMPs) [7].
Overall, UVB stimulates collagen degradation and inhibits procollagen biosynthesis resulting in loss of
collagen content and wrinkle formation, thus inducing skin photoaging [8]. The adverse e↵ects of UVB
exposure can be potentially prevented by the use of natural products with photoprotective properties
and so there is tremendous interest for their exploitation for antiaging product formulations [9].
Propolis is a mixture of resin, bee wax, pollen, and salivary gland secretions produced by
honeybees, primarily for sealing their hives. It consists of polyphenols, flavonoids, terpenoids,
aglycones, and phenolic acids and their esters [10]. Similarly to all honey bee products, its actual
chemical composition varies and largely depends on the geographical region, the local vegetation,
and the collection period [11]. Since ancient times, propolis has been used in wound healing as an
antiseptic, while in recent years it has attracted evenmore attention due to its broad-range biological and
pharmacological properties [12]. Thus, a plethora of studies have investigated the antioxidant [13–18],
antimicrobial [19–21], anti-inflammatory [22–25], immune-modulatory and antitumor activities of
propolis samples collected from di↵erent geographical regions [26–30]. Moreover, it has been shown
that water, ethanol, and methanol extracts of propolis possess strong free radical scavenging activity.
For instance, a study utilizing a topical treatment protocol based on propolis extracts (in mice pre-
or post-UVB exposure) was shown to decrease malondialdehyde formation, which is an advanced
oxidation product of lipid peroxidation and a recognized oxidative stress biomarker. [31]. In addition,
it has been demonstrated that propolis extracts can interfere with viral replication and so can lead to
a reduction of the viral titer [32]. Propolis has a very complex chemical composition, consisting of
a wide range of compounds exerting a diverse range of pharmacological actions (e.g., antibacterial,
anti-inflammatory, healing, anticarcinogenic, antifungal, antiviral, etc.). Of these, ca↵eic acid and
quercetin have been long recognized for their ability to regulate the anti-inflammatory capacity of
propolis by reducing production of eicosanoids and inhibiting the lipoxygenase pathway of arachidonic
acid formation and thus modulating the inflammatory response [33]. Additionally, propolis extracts
were shown to alter the expression profile of pro- and anti-inflammatory genes like TNFa, IFN ,
TLRs, and IL-1, -6, and -10, and modulate monocyte and lymphocyte recruitment [34–36]. Finally,
several studies have reported the antiproliferative e↵ect of propolis against a variety of human cancer
cell lines [37–40] while it also appeared to decrease the expression of cyclins and promote apoptosis
through the induction and/or inhibition of pro-apoptotic and anti-apoptotic genes, respectively [40–42].
However, still little is known regarding the protective potential of propolis against UVR-induced
skin photoaging. Thus, the aim of the present studywas to determine the antiaging potential of propolis
after exposure to UVB. For this reason, propolis samples collected from di↵erent geographic regions of
Greece were extracted by employing n-heptane and methanol extraction protocols. The resulting most
promising propolis extracts were further evaluated for their (i) cytotoxicity profile, (ii) total antioxidant
status (including in vitro activity levels), (iii) ability to inhibit free radical generation (measured as total
protein carbonyl content), and (iv) suppression of photo-induced aging (monitored as inhibition of the
UVB-induced upregulation of MMPs) in human experimental in vitro (immortalized keratinocytes
and reconstituted tissue) skin models.
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2. Materials and Methods
2.1. Propolis Samples Collection, Extraction and Processing
Ten propolis samples (PR_1–PR_10) were collected from di↵erent geographic regions of
Greece during spring or fall season (Table 1). The samples were subjected to two-step sequential
ultrasound-assisted extractionwithn-heptane andmethanol resulting into 10n-heptane (PR_1a–PR_10a)
and 10 methanolic (PR_1b–PR_10b) extracts, all of which were examined for their phenolic and
flavonoid content. In addition, the methanolic extracts were submitted to a high-performance
thin-layer chromatography (HPTLC) profiling and were also evaluated for their cell-free (in vitro)
antioxidant activity, while the most promising extracts were further evaluated for their potential
antimutagenic and antiaging properties.
Table 1. Geographical origin and season of harvest of propolis samples used in the study.
Propolis Sample Origin Season of Harvest
PR_1 Arta Ano Peta Fall 2013
PR_2 Arta Mainland Fall 2013
PR_3 Mt Olympus Fall 2013
PR_4 Drama Fall 2013
PR_5 Arta Mountainous Fall 2013
PR_6 Serres Fall 2013
PR_7 Chania-Stavros Fall 2013
PR_8 Evia Fall 2013
PR_9 Mt Olympus Spring 2013
2.2. Assessment of Total Phenolic Content
The total phenolic content of propolis extracts was determined by the Folin–Ciocalteu
method [43,44]. In brief, 25 µL of propolis extract or standard solution of gallic acid (2.5, 5, 10,
12.5, 20, 25, 40, 50, 80, 100 µg/mL) in DMSO were added to 125 µL of a Folin–Ciocalteu solution
(10%), followed by the addition of 100 µL of 7.5% sodium carbonate in a 96-well plate. The samples
were incubated for 30 min, in darkness, at room temperature. Finally, the absorbance at 765 nm
was measured using a TECAN Infinite m200 PRO multimode reader (Tecan Group, Männedorf,
Switzerland). All measurements were performed in triplicate, the mean values were interpolated in a
gallic acid calibration curve, and the total phenolic content was expressed as mg gallic acid equivalents
(GAE) per gram of dry extract.
2.3. Assessment of Total Flavonoid Content
The total flavonoid content of the propolis extracts was determined by the aluminum chloride
colorimetric assay as previously described [45]. Briefly, 50 µL of propolis extracts or standard solution
of quercetin (2.5, 5, 10, 40, 80, 120, 160, 200 µg/mL) in DMSO were added to 20 µL of 10% of aluminum
chloride solution and then mixed with 160 µL of 95% ethanol. Eighty percent (80%) ethanol was used
as reagent blank. Finally, 20 µL of 1 M sodium acetate were added to the samples and incubated for
40 min, in darkness, at room temperature. The absorbance was measured at 415 nm with a TECAN
Infinite m200 PROmultimode reader (Tecan Group, Männedorf, Switzerland). Total flavonoid contents
were expressed as mg quercetin equivalents (QE) per gram of dry extract. All samples were analyzed
in triplicate.
2.4. Evaluation of Cell-Free Antioxidant Activity by ABTS (2,20-Azino-bis(3-Ethylbenzothiazoline-6-Sulfonic
Acid) and DPPH (2,2-Diphenyl-1-Picrylhydrazyl) Assays
The radical scavenging activity of propolis extracts was estimated by the ABTS and the DPPH
assays as previously described [46–48] with minor modifications. For the ABTS assay, the ABTS radical
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cation (ABTS•+) was produced through the reaction of 7 mMABTS with 2.45 mM potassium persulfate,
in dark, at room temperature for 12 h. The ABTS•+ solution was diluted in water to give an absorbance
of 0.7 ± 0.01 at 734 nm. Then, the ABTS•+ solution (100 µL) was added to 50 µL of di↵erent extract
concentrations (2–50 µg/mL) and incubated, at room temperature, for 10 min in the dark. Finally, the
absorbance was measured at 734 nm in a TECAN Infinite m200 PRO multimode reader (Tecan Group,
Männedorf, Switzerland). In each experiment, the tested sample in ethanol was used as blank and the
ABTS•+ radical solution with H2O was used as control. The radical scavenging capacity of the sample
was expressed as the percentage of ABTS•+ elimination calculated according to the following equation:
% Reduction = {[1 (AD AB)]/AT}100, (1)
where AD is the absorption of the sample, AT the absorbance of control, and AB the absorbance of the
sample without the ABTS radical. Trolox was used as positive control (IC50 = 21.1 µg/mL).
For the DPPH assay, serial dilutions (1.25–5 mg/mL) of propolis extracts were prepared using
dimethylsulfoxide (DMSO) as a solvent. Ten (10) µL of each sample were mixed with 190 µL of DPPH
solution (12.4 mg/100 mL in ethanol) in a 96-well plate and then subsequently incubated, at room
temperature, for 30 min in darkness. Finally, the absorbance was measured at 517 nm in a TECAN
Infinite m200 PRO multimode reader (Tecan Group, Männedorf, Switzerland). All determinations
were performed in triplicate. The % inhibition of the DPPH radical for each dilution was calculated
using the following formula:
% Inhibition = {[1   (AD   AB)]/AT} ⇥ 100. (2)
Gallic acid was used as positive control (IC50 = 4.5 µg/mL). Based on the values derived from the
% inhibition of the radical, reference curves were made for each extract, from which the IC50 values
(µg/mL) were calculated (extract concentration   inhibition %).
2.5. HPTLC Profiling
For the chemical fingerprinting of the methanolic extracts, the samples were applied on HPTLC
plate silica gel 60, 20 ⇥ 10 cm, as 8 mm bands, using an automatic TLC Sampler 4 (ATS4, CAMAG,
Muttenz, Switzerland). The chromatographic separation was performed in the Automatic Developing
Chamber 2 (ADC 2-CAMAG) with a mixture of dichloromethane and methanol (90:10 v/v), up to a
migration distance of 80 mm (from the lower plate edge). The plate was pre-saturated for 5 min with
the mobile phase before plate development and dried automatically for 5 min after plate development.
The plate was scanned (254 and 366 nm) with the GAMAG TLC Scanner 4 and documented under
UV 254 and 366 nm and after spraying with sulphuric vanillin using the TLC visualizer 2 (CAMAG).
The HPTLC plate images were exported from the winCATS software (CAMAG, Muttenz, Switzerland).
2.6. Cell Culture
The human immortalized keratinocyte (HaCaT) cell line was obtained from the American Type
Culture Collection (ATCC, Rockville, USA). Cells were maintained in Dulbecco’s modified Eagle’s
medium high glucose and were supplemented with 10% fetal bovine serum, 100 U/mL penicillin and
100 µg/mL streptomycin (all from Biosera, Boussens, France). Cells were maintained in a humidified
atmosphere at 37  C, 5% CO2 cultured conditions. In all treatments, propolis extracts were dissolved
initially in DMSO and made up to the required concentration with complete cell culture medium (final
maximum concentration of DMSO 0.05% w/v). The sub-confluent cells (60–70%) were treated with
either varying concentrations of propolis extracts or vehicle alone (DMSO, 0.05% (v/v) in media) that
served as a control. Treatments of cells with propolis extracts were done 2 h prior to UVB exposure and
2 h post-UVB exposure followed by 24 h recovery in culture medium. Cell viability was determined by
trypan blue exclusion assay using a hemocytometer.
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2.7. Sulforhodamine B (SRB) Assay
The cytotoxicity profile of propolis extracts was assessed by the SRB assay. Briefly, 5 ⇥ 103 HaCaT
cells per well were seeded in 96-well microplates, cultured for 24 h and then treated with di↵erent
concentrations of propolis extracts (0–200 µg/mL) for 24 h. Then, the cells were fixed by adding 50%
(w/v) cold trichloroacetic acid (TCA) (Applichem, Darmstadt, Germany) in each well and then were
stained with 0.4% (w/v) sulforhodamine B (SRB) (Sigma-Aldrich, Dorset, U.K.) in 1% (v/v) acetic acid
(Scharlau, Barcelona, Spain). The bound dye was dissolved in 10 mM Tris base (Sigma-Aldrich, Dorset,
U.K.) and the absorbance was measured at 570 nm using a multi-plate reader (Tecan, Männedorf,
Switzerland). The % cell survival was calculated using the formula:
[(Sample OD570  media blank OD570)/(mean control OD570  media blank OD570)] ⇥ 100.
The EC50 values (e↵ective concentration that causes 50% decrease in cell viability) of all propolis
extracts were determined by regression analysis using a four-parameter logistic curve with the Sigma
Plot Software v.10 (Systat, San Jose, CA, USA).
2.8. Single Cell Gel Electrophoresis (Comet) Assay
The comet assay was performed as described previously with minor modifications [49]. In brief,
3 ⇥ 105 HaCaT cells were seeded on 60 mm plates, cultured for 24 h, and incubated for 2 h, either with
20 µg/mL of propolis extract (diluted in culture medium) or with normal culture medium. Then, cells
were either irradiated with UVB (55 mJ/cm2) in PBS (treated samples) by using a Bio-Link BLX254
Crosslinker (Vilber Lourmat, Marne-la-Vallée, France) or left untreated (control samples). Then, the
cells were placed for 2 h in culture medium in the presence or absence of propolis samples, and then
recovered for 24 h in culture medium. At the end of the incubation time the cells were collected though
trypsinization, centrifuged at 1500 rpm for 2 min, washed, and resuspended in 1 ⇥ PBS (Biosera, Lewes,
UK). Approximately, 2 ⇥ 104 cells were suspended in 1 mL low-melting-point agarose in PBS pH 7.4
and placed onto super-frosted glass microscope slides pre-coated with a layer of 1% low-melting-point
agarose. The agarose was allowed to set for 2 min at room temperature. Slides were then immersed in
lysis solution (1.2 M NaCl, 100 mMNa2EDTA, 0.1% sodium lauryl sarcosinate, 0.26 M NaOH, pH ⇠ 13)
for 1 h at 4  C, in darkness, under alkaline conditions, to allow the unwinding of DNA. Following
lysis, slides were washed twice with rinse solution (0.03 M NaOH, 2 mM Na2EDTA, pH ~12.3) for
20 min at room temperature. Slides were subjected to electrophoresis in the rinse solution at 13 V
for 25 min, neutralized in dH20 and stained for 20 min with 10 µg/mL propidium iodide. Finally,
they were washed with dH20 and processed for observation on a Nikon ECLIPSE E200 fluorescence
microscope. Image analysis and scoring of DNA damage in arbitrary units (AU) was performed as
previously described [50].
2.9. Determination of Antioxidant Capacity in Cell Lysates
The antioxidant capacity of HaCaT cell lysates was assessed using Cayman’s antioxidant assay kit
(Cayman Chemical, Ann Arbor, MI, USA) according to manufacturer’s instructions. The assay depends
on the ability of antioxidants to prevent the oxidation of ABTS by metmyoglobin. The antioxidant
capacity of cell lysates is compared to that of Trolox, a tocopherol analogue. In brief, 2.5 ⇥ 106 HaCaT
cells were seeded in 100 mm plates, cultured for 2 h in the presence or absence of propolis extracts
(20 µg/mL), washed with PBS (Biosera), and then irradiated with UVB (55 mJ /cm2) or left untreated.
Irradiated and non-irradiated cells were further incubated for 2 h with 20 µg/mL propolis extract
(diluted in culture medium) or with normal culture medium, followed by 24 h recovery in culture
medium. Then, the cells were collected, lysed by sonication in cold lysis bu↵er (5 mM potassium
phosphate pH 7.4, 0.9% sodium chloride, 0.1% glucose) and centrifuged at 10,000⇥ g for 15 min at
4  C. Ten microliters (10 µL) of the supernatants were mixed with 10 µL of metmyoglobin, 150 µL
of chromogen and 40 µL of 441 µM hydrogen peroxide. Absorbance was measured at 750 nm using
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an Enspire Multimode plate reader (Perkin Elmer, Waltham, MA, USA) and interpolated in a Trolox
calibration curve. Antioxidant capacity was expressed as mM Trolox Equivalents.
2.10. Assessment of Protein Carbonyl Content
Protein oxidation was determined by measuring the levels of protein-bound carbonyl groups
after utilizing the protein carbonyl colorimetric assay kit (Cayman Chemical). The assay relies on
the reaction of protein carbonyls with 2,4-dinitrophenylhydrazine (DNPH) and subsequent detection
of the produced hydrazone at 370 nm. Briefly, 2.5 ⇥ 106 HaCaT cells were seeded in 100 mm plates,
cultured for 2 h in the presence or absence of propolis extracts (20 µg/mL), washed with PBS (Biosera),
and then were either irradiated with UVB (55 mJ/cm2) or left untreated. Irradiated and non-irradiated
cells were incubated for 2 h either with 20 µg/mL of propolis extracts (diluted in culture medium)
or with normal culture medium followed by 24 h recovery in culture medium. The cells were then
collected, lysed with sonication in cold lysis bu↵er (50 mMMES pH 6.7, 1 mM EDTA) and centrifuged
at 10,000⇥ g for 15 min at 4  C. Two hundred (200) µL of the supernatants were mixed with 800 µL
DNPH (test) or 800 µL 2.5M HCl (control) and incubated, in the dark at room temperature for 1 h.
Subsequently, the samples were fixed by adding 1 mL 20% TCA, incubated on ice for 5 min and then
centrifuged at 10,000⇥ g for 10 min at 4  C. Pellets were washed once with 10% TCA and then three
times with an ethanol/ethyl acetate mixture. Finally, protein pellets were resuspended in guanidine
hydrochloride and the absorbance was measured at 370 nm using an Enspire Multimode plate reader
(Perkin Elmer). The concentration of protein carbonyls was calculated using the following equation:
Conc. (nmol/mL) = [(CA)/(0.011 µM 1)] (500 µL/200 µL), (3)
where CA is the absorbance of the test sample (after subtracting the absorbance of the control) and was
adjusted to the total protein concentration.
2.11. Human Reconstituted Skin Tissue Model (EpiDermTM EPI-200)
The EpidermTM EPI-200 (MaTek Inc. Ellicott City, MA, USA) is a normal, human, 3D model of
skin epidermis. It consists of human-derived, normal epidermal keratinocytes cultured to reconstitute
a multilayer model of epidermis. This reconstituted tissue is mitotically and metabolically active and
has the capacity to mimic normal human skin epidermis. The tissue was obtained as 24-well culture
plate inserts, which were then equilibrated in EPI-100 assay medium in humidified atmosphere at
37  C, 5% CO2, for 24 h. Throughout the experiments, the reconstituted skin tissues were cultured in
6-well plates with the lower surface being exposed to the EPI-100 assay medium and the apical surface
to air.
2.12. Treatment and UVB Irradiation of EpiDermTM EPI-200
The reconstituted skin tissues were topically treated, in the apical surface, with propolis extracts
(20 µg/mL diluted in EPI-100 assay medium) for 2 h and then washed three times with 1 ⇥ PBS by gentle
pipetting. The culture media were replaced with PBS and the skin tissues were irradiated with UVB
(55 mJ/cm2). Following UVB irradiation, the skin tissues were topically treated again with propolis
extracts for 2 h. Finally, the culture inserts with the skin tissues were placed in fresh EPI-100 assay
medium and were collected 24 h post-treatment with propolis extracts for immunohistochemistry and
real-time PCR analysis.
2.13. Quantitative Real-Time PCR
Total RNA was isolated from skin tissues with Trizol reagent (Life Technologies, Thermo Fisher
Scientific, Waltham, MA, USA) according to the manufacturer’s instructions. The quality and quantity
of the isolated RNA were determined spectrophotometrically and by agarose gel electrophoresis.
Five µg (5 µg) of total RNA was then reverse-transcribed into cDNA using Superscript first-strand
Antioxidants 2019, 8, 125 7 of 20
synthesis kit or RT-PCR (Life Technologies). Subsequently, quantitative real-time PCR was performed
on a StepOne PCR System in MicroAmp® Fast Optical 48-well reaction plates (both from Applied
Biosystems, Thermo Fisher Scientific) using the KAPA SYBR®FAST qPCR Kit (Kapa Biosystems,
Wilmington, DE, USA) under the following conditions: 95  C for 3 min followed by 40 cycles of
95  C for normalization. Each reaction was performed in triplicate and each experiment included
two non-template controls. The sequences ofMMP1,MMP3,MMP7,MMP9, and  -actin primers are
shown in Table 2. Primer specificity was verified by melting curve analysis. For relative quantification
of the transcripts, the formula RQ = 2 DDCt was used.
Table 2. The primers used for real-time PCR.
Gene Forward Primer (50!30) Reverse Primer (50!30)
MMP-1 CCTCGCTGGGAGCAAACA TTGGCAAATCTGGCGTGTAA
MMP-3 GAGGCATCCACACCCTAGGTT ATCAGAAATGGCTGCATCGAT
MMP-7 CTGCATTTCAGGAAAGTTGTATGG AGCTCCTCGCGCAAAGC
MMP-9 GGACGATGCCTGCAACGT CAAATACAGCTGGTTCCCAATCT
 -actin GCGCGGCTACAGCTTCA CTTAATGTCACGCACGATTTCC
2.14. Immunohistochemistry (IHC)
Histopathological examination was performed on 4 mm hematoxylin–eosin stained sections and
the severity of histological lesions were quantified according to the following scoring system. 0: No
lesions; 1: mild lesions; 2: moderate lesions; 3: severe lesions. Lesion severity scores were added to
obtain the histopathological score for all specimens.
For the detection of MMP-1, -3, -7, and -9, the reconstituted skin tissues were collected 24 h
post UVB irradiation plus treatment with propolis extracts, fixed in formalin and then embedded
in para n. Two micron (2 µm) sections were depara nized, rehydrated, treated with 0.3 % H2O2
for 5 min in methanol (to prevent endogenous peroxidase activity) and then were immune-stained
by the peroxidase method (Envision System, DAKO, Carpinteria, CA, USA) and according to the
manufacturer’s recommendations. In brief, after antigen retrieval and endogenous peroxidase blockade,
the sections were blocked with Protein Block Serum-Free (DAKO) and incubated overnight at 4  Cwith
antibodies against MMP-1 (mouse-raised), -3 (rabbit-raised), -9 (mouse-raised) (all from Acris, Herford,
Germany), and -7 (Proteintech, Machester, UK) in 1:750, 1:100, 1:900, and 1:100 dilutions respectively.
Then the sections were incubated with the respective secondary antibodies at room temperature for
60 min. Finally, bound antibody complexes were stained for 10 min with 0.05% diaminobenzidine.
Sections were briefly counterstained withMayer’s hematoxylin, mounted and examined under a Nikon
Eclipse 50i microscope. Control slides were incubated for the same period with non-immunized rabbit
or mouse serum (negative control). Immunohistochemical antibody expression was graded in terms of
the proportion of positively-stained cells after scanning the entire section of each specimen according
to the following semi-quantitatively four scale scoring system (0–3): Sections with >10% stained cells
were evaluated as negative (0); low (1) for 10–20%; moderate (2) for 20–50% stained cells; and high
(3) for >50% positively stained cells. Intensity was not scored separately. Both histopathological
and immunohistochemical evaluation was performed in a blinded fashion under a Nikon Eclipse 50i
microscope by an experienced and skilled pathologist.
2.15. Statistical Analysis
All graphs, data statistical analyses, and calculations of EC50 and EC10 values were performed
by the Graph Pad Prism 5 and Sigma Plot Software v.10 software packages. Results were expressed
as mean ± SD and three independent experiments were performed in triplicate. Statistical analyses
between control and treatment groups were performed using a two-tailed Student’s t-test. A value of
p  0.05 was considered statistically significant.
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3. Results
3.1. Chemical Characterization, Assessment of Radical Scavenging Activity, and Cytotoxicity Profile of
Propolis Extracts
To investigate the potential antimutagenic, antioxidant and antiphotoaging properties of Greek
propolis, ten samples of di↵erent geographic and seasonal origin were collected and subjected to
extractionwith a two-step sequential ultrasound-assistedmethodwith n-heptane ormethanol. A total of
twenty (20) extracts of propolis were obtained, ten following extraction with n-heptane (PR_1a–PR_10a)
and ten more following extraction with methanol (PR_1b–PR_10b). The twenty derived samples were
subsequently screened for their total phenolic content and total flavonoid content (TPC and TFC,
respectively). Methanolic extracts showed significant phenolic and flavonoid content (Table 3) and
were further evaluated for their in vitro radical scavenging activity with the cell-free ABTS and DPPH
methods. Additionally, their metabolic profiling was investigated by HPTLC.
Table 3. Total phenolic content (TPC) and total flavonoid content (TFC) of the ten extracts of n-heptane
(1a–10a) and the ten methanolic propolis extracts (extracts 1b–10b) examined in the present study. Total
phenolic and flavonoid contents are expressed as mg gallic acid and quercetin equivalents (GAE and
QE), respectively, per gram of dry extract.
Propolis Extract TPC C = 0.1 mg/mL mg GAE/g Extract TFC C = 0.1 mg/mL mg QE/g Extract
PR_1a 6.54 14.28
PR_2a 8.87 14.81
PR_3a 8.36 17.09
PR_4a 8.30 19.48
PR_5a 9.29 15.09
PR_6a 10.93 16.78
PR_7a 6.49 6.80
PR_8a 5.37 9.98
PR_9a 10.18 13.45
PR_10a 10.72 11.99
PR_1b 160.64 158.82
PR_2b 151.16 181.43
PR_3b 189.44 155.91
PR_4b 107.73 101.51
PR_5b 205.70 215.76
PR_6b 154.51 134.88
PR_7b 55.67 54.02
PR_8b 93.90 75.09
PR_9b 172.24 169.03
PR_10b 74.79 58.64
The DPPH radical scavenging activity of methanolic propolis samples was found to exhibit
versatile features, varying between 57.60% and 92.07% inhibition, while values of antiradical activity
towards ABTS•+ were 23.83%–53.93% (Table 4). It is important to note that the samples PR_1b,
PR_2b, PR_3b, PR_5b, PR_6b, PR_9b with the higher total phenolic content (TPCs ranged between
151.16 mg/g and 205.70 mg/g GAE; Table 3) showed the highest activity, demonstrating a more than
90% DPPH inhibition at 0.25 mg/mL final concentration and approximately 50% ABTS inhibition at
0.33 mg/mL. It might be claimed that it is di cult to observe direct correlations between TPCs and the
radical scavenging properties of the studied propolis samples. However, in cases of both TPC and
anti-scavenging activity, samples PR_7b and PR_10b, coming from the Greek islands (Chania-Crete
and Samos respectively) exhibited the lowest relevant values. These results confirm previous findings
of other studies on the considerable di↵erences in terms of composition and possible biological impact
of distinctive propolis samples stemming from di↵erent regions.
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Table 4. ABTS and DPPH free radical activity of the ten methanolic propolis extracts examined in the
present study.
Propolis Extract ABTS Inhibition (%) (C = 0.33 mg/mL) DPPH Inhibition (%) (C = 0.25 mg/mL)
PR_1b 50.60 91.79
PR_2b 44.90 91.93
PR_3b 48.41 92.07
PR_4b 32.44 88.62
PR_5b 53.93 91.47
PR_6b 44.80 90.36
PR_7b 31.11 57.60
PR_8b 27.11 83.90
PR_9b 45.37 90.67
PR_10b 23.83 62.99
HPTLC fingerprinting (Figure 1) also revealed that the profile of samples with the higher TPC and
TFC values (PR_1b, PR_2b, PR_3b, PR_5b, PR_6b, PR_9b) is rich in flavonoid compounds, whereas the
profile of samples with the lowest values (PR_7b and PR_10b) is rich in terpenoids.
Our results are in agreement with the data from the previous study of Petkova-Popova et al., as
the propolis samples coming from the mainland of Greece are rich in flavonoids and phenolic acids and
their esters, and therefore possess great antioxidant activity [50]. On the other hand, propolis samples
coming from Greek islands belong to the Mediterranean propolis type, with a specific diterpenic profile
and therefore a lower antioxidant activity [51].
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Figure 1. High-performance thin-layer chromatography (HPTLC) revealed high variability in the
metabolic profile of the methanolic extracts.
To continue with our study, among the propolis samples with the highest antioxidant activity we
selected propolis samples PR_1b and PR_9b, whose raw material were collected in large amounts for
further investigation, and aimed to determine their cytotoxicity profile in the human immortalized
keratinocyte (HaCaT) cell line by employing the SRB assay. Overall, the cells were treated with
increasing concentration of PR_1b and PR_9b for 24 h, and cell viability was determined as percent
of control. The corresponding EC50 and EC10 values (e cient concentrations that cause 50% and
10% decrease in cell viability respectively) of each propolis extract were also evaluated. As shown
in Figure 2a,b, the observed patterns of cytotoxicity were very similar between all extracts with the
EC50 and EC10 values ranging approximately from 26–28 µg/mL to 9–11 µg/mL respectively (Table 5).
For all subsequent experiments the concentration of 20 µg/mL of propolis extracts was chosen as at the
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given concentration cell viability remained more than 90% following 24 h incubation with the propolis
extracts compared to control.
Table 5. The EC50 and EC10 values of the propolis extracts PR_1b and PR_9b.
Propolis Extract EC50 (µg/mL) 1 EC10 (µg/mL) 1
PR_1b 57.34 ± 3.45 22.18 ± 0.87
PR_9b 69.30 ± 2.76 23.32 ± 0.76
1 Determined from the dose-response curves of Figure 1. The results are shown as the mean ± SD of three
independent experiments.Antioxidants 2019, 8, x FOR PEER REVIEW 10 of 20 
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Figure 2. Cytotoxicity profile of propolis extracts in human immortalized keratinocyte (HaCaT) cells. 
Cells were incubated for 24 h with increasing concentrations (0–200 μg/mL) of each propolis extract: 
PR_1b (a) and PR_9b (b). Cell viability was determined by the SRB assay. The results are shown as 
the mean ± SD of three independent experiments. 
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Single cell gel electrophoresis assay (comet assay) under alkaline conditions was used to detect 
single- and double-strand breaks in the DNA. To determine the antioxidant and photoprotective 
properties of the selected propolis extracts on the formation of DNA strand breaks, HaCaT cells were 
pre-incubated with 20 μg/mL of PR_1b, and PR_9b and then exposed to UVB (55 mJ/cm2). None of 
the propolis extracts did cause significant increase in DNA damage levels compared to control 
(untreated cells) (Figure 3A,B). UVB irradiation of HaCaT cells induced significant increase in DNA 
damage levels which were considerably decreased in the case of cell exposure to pPR_1b (Figure 3A), 
and PR_9b (Figure 3B) propolis samples, suggesting promising photoprotective properties. 
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Figure 3. Propolis extracts protect HaCaT cells from UVB-induced DNA damage. Cells were pre-
treated for 2 h with 20 μg/mL of PR_1b (a) and PR_9b (B) and either irradiated with UVB 55mJ/cm2 
or left untreated (non-irradiated). Irradiated and non-irradiated cells were further incubated for 2 h 
in the presence or absence of propolis samples, recovered for 24 h in culture medium, and subjected 
to cell gel electrophoresis (comet) assay. The scoring was expressed in arbitrary units (AU) and was 
based on the extent of DNA damage under each experimental condition. The data presented are the 
mean ± SD of three independent experiments performed in duplicates. *p ≤ 0.05, significantly different 
from the irradiated cells. 
3.3. Protection of HaCaT Cells by Propolis Extracts against UVB-Induced Oxidative Damage and 
Photoaging 
Phase-contrast microscopy and the trypan blue exclusion assay were utilized for determining 
the effect of PR_1b and PR_9b against UVB-induced cytotoxicity in HaCaT cells (Figure 4). As noted, 
UVB irradiation resulted in a significant reduction of cell viability accompanied by morphological 
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3.2. Propolis Extracts Protect Human Epidermal Keratinocytes (HaCaT) Cells from UVB-Induced
DNA Damage
Single cell gel electrophoresis assay (comet assay) under alkaline conditions was used to detect
single- and double-strand breaks in the DNA. To determine the antioxidant and photoprotective
properties of the selected propolis extracts on the formation of DNA strand breaks, HaCaT cells were
pre-incubated with 20 µg/mL of PR_1b, and PR_9b and then exposed to UVB (55 mJ/cm2). None of the
propolis extracts did cause significant increase in DNA damage levels compared to control (untreated
cells) (Figure 3a,b). UVB irradiation of HaCaT cells induced significant increase in DNA damage levels
which were considerably decreased in the case of cell exposure to pPR_1b (Figure 3a), and PR_9b
(Figure 3b) propolis samples, suggesting promising photoprotective properties.
3.3. Protection of HaCaT Cells by Propolis Extracts against UVB-Induced Oxidative Damage and Photoaging
Phase-contrast microscopy and the trypan blue exclusion assay were utilized for determining
the e↵ect of PR_1b and PR_9b against UVB-induced cytotoxicity in HaCaT cells (Figure 4). As noted,
UVB irradiation resulted in a significant reduction of cell viability accompanied by morphological
changes of HaCaT cells (Figure 4b). On the other hand, pretreatment with PR_1b and PR_9b before
UVB exposure prevented the UVB-induced decrease in HaCaT cell viability (Figure 4a,b).
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3.3. Protection of HaCaT Cells by Propolis Extracts against UVB-Induced Oxidative Damage and 
Photoaging 
Phase-contrast microscopy and the trypan blue exclusion assay were utilized for determining 
the effect of PR_1b and PR_9b against UVB-induced cytotoxicity in HaCaT cells (Figure 4). As noted, 
UVB irradiation resulted in a significant reduction of cell viability accompanied by morphological 
Figure 3. Propolis extracts protect HaCaT cells fromUVB-inducedDNAdamage. Cells were pre-treated
for 2 h with 20 µg/mL of PR_1b (a) and PR_9b (b) and either irradiated with UVB 55mJ/cm2 or left
untreated (non-irradiated). Irradiated and non-irradiated cells were further incubated for 2 h in the
presence or absence of propolis samples, recov red for 24 h in culture medium, and subjected to cell gel
electrophoresis (comet) assay. The scoring was expressed in arbitrary units (AU) and was based on the
extent of DNA damage under each experimental condition. The data presented are the mean ± SD of
three independent experiments performed in duplicates. * p  0.05, significantly di↵erent from the
irradiated cells.
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Figure 4. Protection of HaCaT cells by propolis extracts against UVB-induced cell cytotoxicity. Cells 
were pre-treated for 2 h with 20 μg/mL of propolis extracts, irradiated with 55 mJ/cm2 UVB and 
further incubated in the presence or absence of propolis extracts for 2 h. After a 24 h recovery, the 
remaining cell viability was assayed both through trypan blue exclusion assay (a) and phase contrast 
microscopy (10×) (b). (A) The data presented are the mean ± SD of three independent experiments 
performed in triplicate. *** p ≤ 0.001, **** p ≤ 0.0001 significantly different from the UVB-irradiated 
cells. (B) Phase contrast microscopy of non-irradiated (i) and UVB-irradiated (ii) cells as well as those 
treated with PR_1b and PR_9b (iii and iv, respectively). Figures are representative of ten random 
fields for each condition examined in triplicate. 
Next, we aimed to investigate whether the observed inhibition of UVB-induced cytotoxicity is 
due to the antioxidant activity of the propolis samples. HaCaT cells were treated for 2 h with either 
PR_1b or PR_9b prior to UVB irradiation, followed by 2 h post-treatment in the presence or absence 
of the propolis extracts and the antioxidant capacity was measured in cell lysates by employing the 
Trolox antioxidant assay. Overall, antioxidant activity levels remained statistically non-significant 
between untreated and UVB-irradiated cells under conditions of exposure of the cells in the absence 
or the presence of the two propolis samples (Figure 5). On the contrary, supplementation with either 
Figure 4. Protection of HaCaT cells by propolis extracts against UVB-induced cell cytotoxicity. Cells
were pre-treated for 2 h with 20 µg/mL of propolis extracts, irradiated with 55 mJ/cm2 UVB and further
incubated in the presence or absence of propolis extracts for 2 h. After a 24 h recovery, the remaining
cell viability was assayed both t rough trypan blue exclusion assay (a) and phase contrast microscopy
(10⇥) (b). (A) The data presented are the mean ± SD of three independent experiments performed in
triplicate. *** p  0.001, **** p  0.0001 significantly di↵erent from the UVB-irradiated cells. (B) Phase
contrast microscopy of non-irradiated (i) and UVB-irradiated (ii) cells as well as those treated with
PR_1b and PR_9b (iii and iv, respectively). Figures are representative of ten random fields for each
condition examined in triplicate.
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Next, we aimed to investigate whether the observed inhibition of UVB-induced cytotoxicity is
due to the antioxidant activity of the propolis samples. HaCaT cells were treated for 2 h with either
PR_1b or PR_9b prior to UVB irradiation, followed by 2 h post-treatment in the presence or absence of
the propolis extracts and the antioxidant capacity was measured in cell lysates by employing the Trolox
antioxidant assay. Overall, antioxidant activity levels remained statistically non-significant between
untreated and UVB-irradiated cells under conditions of exposure of the cells in the absence or the
presence of the two propolis samples (Figure 5). On the contrary, supplementation with either sample,
PR_1b or PR_9b, under the same experimental conditions, significantly inhibited UVB-induced protein
oxidation (measured as protein carbonyl content) in HaCaT cells (Figure 5b).
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Figure 5. Propolis extracts protect HaCaT cells from UVB-induced oxidative protein damage. Cells 
were pretreated with 20 μg/mL of either PR_1b or PR_ 9b for 2 h and then exposed to UVB irradiation 
(55 mJ/cm2) or left untreated. Following UVR exposure, cells were incubated in the presence or 
absence of propolis extracts for 2 h followed by a 24 h recovery in culture medium before being 
processed for estimation of oxidative status. (a) Total antioxidant content and activity of cell lysates 
were assessed by the ABTS oxidation assay and expressed as fold change in Trolox equivalents. (b) 
Protein oxidation estimated by measuring the protein carbonyl levels with the DNPH colorimetric 
assay. The concentration of the protein carbonyls was determined, adjusted to the total protein 
concentration, and was expressessed as fold change compared to the untreated cells. Data shown are 
the mean ± SD of three independent experiments performed in triplicate. ** p ≤ 0.01, significantly 
different from the UVB-irradiated cells. 
3.4. Propolis Extracts Inhibit UVB-Induced Overexpression of Matrix Metalloproteinases (MMPs) in a 
Human Reconstituted Skin Model 
To further evaluate the protective effects of propolis extracts against UVB-induced photoaging, 
we employed a human reconstituted skin model known as EpidermTM EPI-200. This is a normal, 
human, 3D model of epidermal tissue, consisting of neonatal-derived epidermal keratinocytes that 
have been cultured to reconstruct a multilayer model of epidermis. It is mitotically and metabolically 
active and very closely mimics the human skin. 
In this set of experiments, the apical surface of the skin tissues was pre-treated for 2 h with PR_1b 
or PR_9b, exposed to 55 mJ/ cm2 UVB irradiation and post-treated with the propolis extracts for 2 h. 
Following 24 h, hematoxylin and eosin (H&E) staining was performed to identify potential 
morphological changes and skin lesions. UVB exposure caused severe cellular damage characterized 
by necrotic keratinocytes (Figure 6B) compared to control (Figure 6A). Supplementation of the UVB-
irradiated skin tissues with PR_1b and PR_9b resulted in noticeable tissue changes including 
reducing keratinocyte layers and scattered sunburn cells (pyknotic nuclei) for PR_1b (Figure 6C) as 
well as cytoskeletal blebbing, intercellular edema, and few sunburned cells for PR_9b (Figure 6D). 
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wer pretreated with 20 µg/mL of either PR_1b or PR_ 9b for 2 h and then exposed to UVB irradiation
(55 mJ/cm2) or left untrea ed. Following UVR exposure, cells were incubated in th presence o absence
of propolis ext acts for 2 h followed by a 24 h recovery in culture medi m b for being pr c ss d
for estimation of oxidative status. (a) Total antioxidant c ntent and activity of cell lysat s were
assessed by the ABTS oxidation assay and expressed as fold change in Trolox equivalents. (b) Protein
oxidation estimated by measuring the protein ca bonyl levels with the DNPH colorimetric assay.
The concentration of the protein carbonyls was determined, adjusted to the total protein concentration,
and was expressessed as fold change compared to th untre ted cells. Data shown are the mean ± SD
of three independent experim nts p rformed in triplicate. ** p  0.01, significantly di↵erent from the
UVB-irradiated cells.
3.4. Propolis Extracts Inhibit UVB-Induced Overexpression of Matrix Metalloproteinases (MMPs) in a Human
Reconstituted Skin Model
To further evaluate the protective e↵ects of propolis extracts against UVB-induced photoaging,
we employed a human reconstituted skin model known as EpidermTM EPI-200. This is a normal,
human, 3D model of epidermal tissue, consisting of neonatal-derived epidermal keratinocytes that
have been cultured to reconstruct a multilayer model of epidermis. It is mitotically and metabolically
active and very closely mimics the human skin.
In this set of experiments, the apical surface of the skin tissues was pre-treated for 2 h with
PR_1b or PR_9b, exposed to 55 mJ/ cm2 UVB irradiation and post-treated with the propolis extracts
for 2 h. Following 24 h, hematoxylin and eosin (H&E) staining was performed to identify potential
morphological changes and skin lesions. UVB exposure caused severe cellular damage characterized
by necrotic keratinocytes (Figure 6b) compared to control (Figure 6a). Supplementation of the
UVB-irradiated skin tissues with PR_1b and PR_9b resulted in noticeable tissue changes including
reducing keratinocyte layers and scattered sunburn cells (pyknotic nuclei) for PR_1b (Figure 6c) as
well as cytoskeletal blebbing, intercellular edema, and few sunburned cells for PR_9b (Figure 6d).
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To further evaluate the protective effects of propolis extracts against UVB-induced photoaging, 
we employed a human reconstituted skin model known as EpidermTM EPI-200. This is a normal, 
human, 3D model of epidermal tissue, consisting of neonatal-derived epidermal keratinocytes that 
have been cultured to reconstruct a multilayer model of epidermis. It is mitotically and metabolically 
active and very closely mimics the human skin. 
In this set of experiments, the apical surface of the skin tissues was pre-treated for 2 h with PR_1b 
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Following 24 h, hematoxylin and eosin (H&E) staining was performed to identify potential 
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Figure 6. Evaluation of the protective effect of propolis extracts against UVB-induced skin damage. 
EpidermTM EPI-200 reconstituted human skin tissues were treated on their apical surface with 20 
μg/mL of either PR_1b or PR_9b for 2 h, washed with PBS, and then exposed to 55 mJ/cm2 of UVB 
irradiation. After exposure, the apical surface of the tissues was incubated in the presence or absence 
of each of the propolis extracts for 2 h, then washed with PBS and placed in culture medium. After 24 
h, the tissues were harvested and sections were taken. Representative figures (at 400× magnification) 
of eosin and hematoxylin staining of untreated tissues (a), UVB-irradiated skin tissues (b) and tissues 
treated with UVB and either PR_1b (c) or PR_9b (d).  
Since induction of matrix metalloproteinases (MMPs) is a critical mechanism of photoaging, we 
analyzed by quantitative PCR the expression levels of MMPs in skin tissues that had been irradiated 
with UVB and then treated with either PR_1b or PR_9b (Figure 7). Significant overexpression of 
MMP-1, -3, -7, and -9 was documented in the UVB-exposed tissues compared to the untreated skin. 
Incubation of the UVB-irradiated reconstituted skin with PR_1b led to a variable degree of reduction 
in the expression levels of MMP-3, -7, and -9 (Figure 7A). On the other hand, a significant increase in 
the mRNA expression levels of MMP-1 was noticed. Similar results were obtained in the case of the 
PR_9b propolis extract (Figure 7B). 
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Figure 7. Propolis extracts decrease the mRNA levels of MMPs after UVB irradiation in a reconstituted 
human skin model. EpidermTM EPI-200 human skin tissues were pretreated with 20 μg/mL of either 
PR_1b (a) or PR_9b (b), for 2 h prior to UVB irradiation (55 mJ/cm2) and incubated again with or 
without the propolis extracts for 2 h. After 24 h, the tissues were harvested, and total RNA was 
extracted. Quantitative real-time PCR was utilized to determine levels of MMP-1, -3, -7, and -9 mRNA. 
Expression levels of MMP-1, -3, -7, and -9 were normalized to those of β-actin. Untreated cells served 
as a reference sample. The formula RQ = 2−ΔΔCt was used in order to quantitate the data. The graph is 
representative of three independent experiments performed in triplicate. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 
0.001, **** p ≤ 0.0001. 
To further validate the effect of propolis extracts on the UVB-induced overexpression of MMPs 
at protein level, immunohistochemical analysis was performed. As expected, UVB irradiation 
induced an upregulation of all the MMPs examined, especially MMP-3 and -9 (Figures 8B,F,J,N), 
compared to control (Figure 8A). In consistence with the real-time PCR data obtained from the skin 
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Since induction of atrix etalloproteinases ( Ps) is a critical echanis of photoaging, we
analyzed by quantitative PCR the expression levels of Ps in skin tissues that had been irradiated
with UVB and then treated with either PR_1b or PR_9b (Figure 7). Significant overexpression of
P-1, -3, -7, and -9was docu ented in the UVB-exposed tissues co pared to the untreated skin.
Incubation of the UVB-irradiated reconstituted skin with PR_1b led to a variable degree of reduction in
the expression levels ofM P-3, -7, and -9 (Figure 7a). On the other hand, a significant increase in the
mRNA expression levels ofMMP-1was noticed. Similar results were obtained in the case of the PR_9b
propolis extract (Figure 7b).
To further validate the e↵ect of propolis extracts on the UVB-induced overexpression of MMPs at
protein level, immunohistochemical analysis was performed. As expected, UVB irradiation induced
an upregulation of all the MMPs examined, especially MMP-3 and -9 (Figure 8B,F,J,N), compared
to control (Figure 8A). In consistence with the real-time PCR data obtained from the skin tissues,
treatment with PR_1b resulted in a significant decrease in the protein expression levels of MMP-3 and
-9 (Figure 8C,G,O) and to a lesser extent of MMP-7 (Figure 8K). Similar results were observed with
PR_9b (Figure 8D,H,L,P). Contrary to what was observed for MMP-1 mRNA levels, both propolis
extracts also resulted in a significant decrease of the UVB-upregulated MMP-1 protein, suggesting that
propolis may exert regulatory functions at post-transcriptional level.
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To further validate the effect of propolis extracts on the UVB-induced overexpression of MMPs 
at protein level, immunohistochemical analysis was performed. As expected, UVB irradiation 
induced an upregulation of all the MMPs examined, especially MMP-3 and -9 (Figures 8B,F,J,N), 
compared to control (Figure 8A). In consistence with the real-time PCR data obtained from the skin 
Figure 7. Propolis extracts decrease the mRNA levels of Ps after UVB irradiation in a reconstituted
human skin model. EpidermTM EPI-200 human skin tissues were pretreated with 20 µg/mL of either
PR_1b (a) or PR_9b (b), for 2 h prior to UVB irradiation (55 mJ/cm2) and incubated again with or
without the propolis extracts for 2 h. After 24 h, the tissues were harvested, and total RNA was
extracted. Quantitative real-time PCR was utilized to determine levels ofMMP-1, -3, -7, and -9mRNA.
Expression levels ofMMP-1, -3, -7, and -9were normalized to those of  -actin. Untreated cells served
as a reference sample. The formula RQ = 2 DDCt was used in order to quantitate the data. The graph
is representative of three independent experiments performed in triplicate. * p  0.05, ** p  0.01,
*** p  0.001, **** p  0.0001.
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Figure 8. Propolis extracts protect from UVB-induced overexpression of MMPs in a reconstituted
human skin model. EpidermTM EPI-200 human skin tissues were pretreated with 20 µg/mL of either
PR_1b or PR_9b, for 2 h prior to UVB irradiation (55 mJ/cm2) and incubated again in the presence
or the absence of the propolis extracts for 2 h. After 24 h recovery in culture medium, the tissues
were harvested, sections were taken, and immunostaining was performed to determine the protein
expression levels of M P-1 (A–D), -3 (E– ), -7 (I–L), and -9 (M–P). Representative figures (at 400⇥
magnification) f untreated (A,I,J,M) as well as UVB-ir i t (B,F, , ), B/PR_1b (C,G,K,O) and
UVB/PR_9b (D,H,L,P) treated human ski tissues (inte sity scale score staining: A = 1, B = 3,
C = 1.5, D = 1.5, E = 1, F = 3, .5, H = 1.5, I = 1, J = 2, K = 2, L = 1.5,M 1, N = 3, O = 2, P = 1.5).
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4. Discussion
Exposure to solarUVR is considered to be akey factor in thedevelopment of certain skinpathologies
like inflammation, skin cancer, and photoaging [52,53]. UVR exhibits its strong cytotoxic e↵ect both
through direct targeting of DNA aswell as through the production of reactive oxygen species (ROS) [54].
Therefore, the identification of natural compounds with a strong, multifaceted, cytoprotective e↵ect
against UVR is crucial for addressing the demand for e↵ective, natural cosmeceutical products.
For our study, 10 propolis samples from di↵erent regions of Greece were collected and 20 propolis
extracts (10 n-heptane and 10 methanol extracts) were produced. Initially, we analyzed the total
phenolic and flavonoid content of all extracts. The methanolic extracts showed high phenolic and
flavonoid content and were forwarded for the evaluation of their in vitro antioxidant capacity. Based
on their in vitro antioxidant capacity the methanolic extracts appeared to be more promising. We
selected the methanolic extracts PR_1b and PR_9b to continue with our study and further investigated
their antioxidant and photoprotective properties. The range of the non-toxic concentration of the
propolis extracts was determined in HaCaT cells and their capacity to inhibit the oxidative and DNA
damaging e↵ects of UVB was further evaluated. Finally, the antiaging properties of the extracts were
determined through analyzing the e↵ect of the propolis on the UVR-induced upregulation of MMPs in
a reconstituted human skin model. Our results indicated that the selected methanolic propolis extracts
exhibited significant in vitro antioxidant capacity and antimutagenic activity. Furthermore, the PR_1b
and PR_9b extracts were capable of maintaining cell viability and inhibiting protein oxidation of HaCaT
cells under UVB exposure conditions. Regarding the antiaging activity of the extracts, treatment with
the PR_1b and PR_9b extracts protected the UVB-irradiated skin tissues from severe damage and
total keratinocyte necrosis and led to reduced UVB-dependent upregulation of theMMP-3,MMP-7,
andMMP-9 genes as well as lower MMP-1, MMP-3, and MMP-9 protein levels in comparison to the
untreated UVB-irradiated skin tissues.
Even though the comparison between extracts produced by propolis samples from di↵erent
geographic regions is particularly complex as a result of the significant di↵erences in their chemical
compositions due to the variability of the local flora on the collection sites, in general, our results are in
line with previous experimental data supporting the protective properties of propolis. Specifically,
the antioxidant capacity of propolis extracts is considered to be well established, specifically through
commonly used in vitro antioxidant methods. In fact, in most cases the antioxidant activity of
the extracts appeared to have a direct correlation with their total phenolic and/or total flavonoid
content [55–60]. In our study, all the examined methanolic extracts of propolis exhibited comparable
in vitro antioxidant activity (23.83% to 53.93% and 57.60% to 92.07% for ABTS and DPPH, respectively)
regardless of the range of their total phenolic (55.67 to 205.70 mg GAE/g dry extract) and/or flavonoid
(54.02 to 215.76 mg QE/g dry extract) content. This finding could be explained by the fact that while
flavonoid and phenolic compounds are major constituents of propolis, it also consists of a huge variety
of additional chemical compounds, some of which possess certain antioxidant properties [61].
Additionally, our results showed that all the examinedmethanolic extracts demonstrated protective
e↵ects against the DNA-damaging potential of UVB radiation. Our data agree with previous reports
describing the antimutagenic activity of propolis extracts [62–66]. For instance, Roberto et al. reported
that treatment with ethanolic extracts of green type Brazilian propolis significantly reduced the methyl
methanesulfonate (MMS)-induced DNA damage in the rat hepatoma cell line HTC [63], while Yalcin
et al. demonstrated that pre-treatment with ethanolic extract of Turkish propolis substantially reduced
the  -ray-induced DNA damage of foreskin fibroblast cells [64]. Similarly, Benkovic et al. showed
that pre-treatment with ethanolic propolis extracts was e cient to protect human white blood cells
from the genotoxic e↵ects of  -radiation, while administration of ethanolic propolis extracts to mice
prior to their irradiation with  -rays resulted in reduced DNA damage levels of their white blood
cells and in higher survival rates [65,66]. To the extent of our knowledge, this is the first time that the
antimutagenic activity of propolis extracts against UVR is being demonstrated in human keratinocyte
HaCaT cells.
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Among the propolis samples, PR_1b and PR_9b were selected for further investigation. In our
study, treatment with the selected propolis extracts PR_1b and PR_9b protected HaCaT cells from the
UVB-induced protein oxidation and cytotoxicity. Our findings are supported by previous data from
Kim et al. who reported that treatment with propolis led to inhibition of UVA-induced apoptosis and
caspase-3 activation accompanied by attenuated UVA-dependent ROS formation in HaCaT cells [67].
Similarly, Fonseca et al. demonstrated that the oral administration of propolis extracts to hairless mice
prevented the UV-induced depletion of glutathione (GSH) [68], while Bolfa et al. showed that topical
treatment of propolis extracts to mice reduced the UVB-induced generation of malondialdehyde and
re-established glutathione peroxidase activity [31].
Finally, only a few data are currently available in the literature on the antiaging properties of
propolis. For instance, Ebadi et al. reported that pre-treatment of human dermal fibroblasts with
propolis extracts prior to UVB exposure resulted in increased cell viability and reduced numbers of
senescent,  -galactosidase-positive cells and led to upregulation of the FOXO3A and NGF genes in
comparison to the untreated dermal fibroblasts [69]. Regarding the ability of propolis to down-regulate
the expression of certain MMPs, Jin et al. showed that propolis extracts significantly inhibited the
MMP-9 activity in hepatocarcinoma cells [70], while Saavedra et al. demonstrated that treatment
of activated macrophage cells with ethanolic propolis extracts downregulated the expression of
MMP-9 in a dose-dependent manner [71]. However, these studies were focused on the antitumoral
and anti-inflammatory properties of propolis and consequently were not conducted with skin cell
models. MMPs are broad substrate specificity endopeptidases mediating the degradation of di↵erent
components of the extracellular matrix (ECM) involved in various pathophysiological processes
including, inflammation, cancer, would healing and photoaging. In skin, MMPs are secreted by
keratinocytes and dermal fibroblasts in response to various stimuli including cytokines, oxidative
stress, and UVR. [72]. Although the role of MMPs expressed in dermis is well characterized in
relation to photoaging and wrinkle formation as they degrade ECM, less is known for the role of
MMPs in keratinocytes as UVB sensors. Other studies, as well, have documented the induction of
MMP-9 [73], MMP-1 [74] and MMPs-13, 12, 3, 10 [75] as a result of UVB irradiation suggesting that
their up-regulation appears to be a direct e↵ect of UVB irradiation, thus potentially contributing to
photoaging through modulating apoptotic and inflammatory responses involved in skin photodamage.
However, the detailed mechanisms by which MMPs in keratinocytes mediate tissue damage require
further elucidation. To the extent of our knowledge, this is the first time that the inhibitory e↵ect of
propolis extracts on the UV-induced upregulation of a panel of aging-related MMPs is reported both in
HaCaT cells and further validated in a reconstituted human skin model suggesting a novel role of
propolis as a protective means against UVB-induced skin photodamage.
5. Conclusions
The results of this study support the conclusion that Greek propolis extracts possess strong
antioxidant, antimutagenic, and antiaging properties, and can protect keratinocytes from the
multifaceted deleterious e↵ects of UVR. Thus, they could be considered as promising candidates for
the development of novel and highly e↵ective cosmeceuticals. Future research is required though
to further validate the biological activities of Greek propolis extracts, define in detail the underlying
molecular mechanism(s) of action and link their cytoprotective actions with the structural elucidation
of their active ingredients.
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